Thank you for submitting your manuscript for consideration by The EMBO Journal. It has now been seen by three referees whose comments are shown below. As you will see while all three referees consider the study as interesting and while referee 2 is a bit more positive the other two referees think that deeper insight into the mode of action of MIEF1 in the regulation of Drp1 recruitment and/or activity would be required before the study will be sufficiently insightful to justify publication here. It thus becomes clear that apart from an adequate response to the specific points raised regarding the study at this level of mechanistic understanding at least some deeper insight into the mode of action of MIEF1 along the lines suggested by the referees will need to be included. We will be able to consider a revised manuscript if the study can be developed further into this direction. The revised manuscript will need to be seen again by the referees and a final decision can only be made at that stage.
I should remind you that it is EMBO Journal policy to allow a single round of revision only and that, therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript as well as on the final assessment by the referees.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Peer Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process initiative, please visit our website: http://www.nature.com/emboj/about/process.html Thank you for the opportunity to consider your work for publication. I look forward to your revision in due course. Please do not hesitate to contact us at any time should you wish to consult with us on any aspect of the revision.
Yours sincerely, Editor
The EMBO Journal REFEREE REPORTS Referee #1 (Remarks to the Author):
Zhao et al in "The vertebrate-specific outer membrane protein MIEF1 recruits Drp1 to mitochondria but promotes mitochondrial fusion", report the discovery of a novel, vertebrate-specific protein named MIEF1, which acts as a captor of Drp1 on mitochondria with subsequent inhibition of the fission activity of the protein. Albeit proposing a good characterization of MIEF1 (subcellular localization, site of interaction with Drp1 and hFis1, effect of overexpression and deletion on mitochondrial morphology) what pertains to the mechanism of recruitment of Drp1 to mitochondria is far from being clarified by the proposed data, which is therefore insufficient to justify publication in this journal at this moment.
In particular, these very relevant points should be investigated in order to rely MIEF1 to the pathway of Drp1 recruitment and action on mitochondria. 1. authors should explain better the approach used to identify MIEF1 in the public database. It appears that this database allows visual inspection of the overexpression of the tagged protein and hence authors used the images to address the effect of the overexpressed fusion protein on mitochondrial morphology. This must be explained. 2. authors disregard the possibility that MIEF1 participates in mitochondrial fusion. This must be checked, by 1. measuring mitochondrial fusion rates; 2. measuring the effect of its overexpression in cells deficient for fusion components; 3. levels of MIEF should be tested in different cell lines and tissues and related to the observed mitochondrial morphology. 4. Drp1 is known to migrate to mitochondria, oligomerize and promote fission. If MIEF1 is the key player in the pathway of Drp1 migration from the cytosol to mitochondria by playing together with hFis, the analysis of expression levels of the endogenous versions of the three proteins during the process of MIEF1 mediated mitochondrial fusion is required. 5. Overexpression of the dominant negative K38A version of Drp1 results in mitochondrial elongation not because of a block of Drp1 migration to mitochondria, but due to the inability of the protein to hydrolyze GTP during pinching off of the mitochondrial membranes as fission is going on-the comparison of the effect produced by MIEF1 and Drp1K38A is therefore not justified as long as the authors do not demonstrate that MIEF1 inhibits mitochondrial fragmentation by blocking the ability of Drp1 to hydrolyze GTP. 6. The fact that both MIEF1 full-length and MIEF1 lacking the transmembrane region are equally efficient in promoting mitochondrial fusion is very confusing. Does this mean that MIEF1 overexpression equals Drp1 downregulation? Or do they belong to two different pathways? This must be addressed by checking the effect of Drp1 silencing on overexpression of the delta-TM MIEF1; and of overexpression of Drp1 constitutively located at the mitochondria (S637A) together with MIEF1 7. the role of Fis1 in mediating mitochondrial fission has been recently questioned. This must be discussed (see the recent work by Mihara and colleagues). 8. Three years ago, three different laboratories found that protein kinase A and calcineurin are involved in the pathway of recruitment of Drp1 from the cytosol to mitochondria. Where lies MIEF1 in this pathway? Upstream or downstream? The authors do not explain whether MIEF1 is able to block posttranslational modifications of Drp1 that were previously proposed to underlie Drp1 regulation. This should be addressed using the specific mutants of Drp1 at the phosphorylation sites described above, and by measuring calcineurin activity in cells overexpressing MIEF1 9. what is the role of MIEF1 during "physiological" fragmentation of mitochondria by Drp1? In other words, is it possible to inhibit translocation of Drp1 and hence fragmentation induced by Ca2+ overload by overexpressing MIEF1?
Referee #2 (Remarks to the Author):
The authors report on a novel mitochondrial outer membrane protein, MIEF1, which plays a role in regulating mitochondrial fusion and fission processes. A mechanism explaining the recruitment of the mitochondrial fission factor Drp1 to the outer membrane is presented. In the proposed model DRP1 binds to MIEF1 which instead of promoting mitochondrial fission rather sequesters DRP1 in an inactive state. The mitochondria thus do not undergo any fission events whereas fusion was suggested to persist. On the contrary, hFis1expression reverses this effect of MIEF1 indicating that the interplay between MIEF1 and hFis1 plays a crucial role in regulating the fission machinery. The study is of major general interest and the experimental data are of high technical quality which largely support the conclusions of the authors. Only one major point and some minor points need to be addressed in my opinion.
Major point: The authors claim that MIEF1 promotes mitochondrial elongation via ongoing fusion and inhibiting DRP1 function. Alternatively, MIEF1 e.g. via its homotypic interactions could promote mitochondrial clustering while at the same time mitochondrial fusion and fission is inhibited. The authors fail to address directly whether fusion is affected by MIEF1. This needs to be done e.g. by a PA-GFP based assay or by an in vivo fusion assay. In the same direction, it rather looks that MIEF1 primarily promotes clustering of tubular mitochondria and that outer membrane, inner membrane fusion and fission is blocked. This is supported by their own EM data which show a major amount of docked outer membranes. On page 8, top paragraph the authors propose partial fusion of outer membranes (referring to figure 2K2 and 2K3). This is not convincingly shown as it rather appears that the OM is docked over the entire length of the membrane surface. The authors should thus investigate specifically also whether outer membrane fusion is inhibited or not. For this an in vivo fusion assay in combination with an outer membrane localized GFP is suggested.
Minor points:
To further corroborate the interaction between MIEF1 and Drp1 and the role of MIEF1 in recruiting DRP1 it would be good to target MIEF1 to other cellular membranes (e.g. cell membrane, Golgi etc.). Is DRP1 partly recruited to this artificial membrane localization as well? Do the different MIEF1 variants alter DRP1 distribution? In addition to the wild type MIEF1 (as shown in figure 8D ) a colocalization analysis of the MIEF1 variants with labeled mitochondria (Mitotracker), and DRP1 should be shown -possibly as a supplemental material. Fig. 2 . The arrangement of EM micrographs is somehow confusing and one cannot get the information which image is the magnification of which one. Further there appears to be an error in the legend of figure 2 on page 32 stating that 2H and 2I are higher magnifications of 2G and 2H. It should say "(F and G, respectively)". This manuscript presents a new factor in the regulation of mitochondrial morphology, MIEF1. Identified through a GFP-mapping project by Simpson, MIEF1 was shown to be localized to mitochondria, which prompted the authors to investigate further. MIEF1 contains a single, Nterminal transmembrane segment, but does not seem to contain any other identifiable domains. The overexpressed protein forms dimers and oligomers, as seen by crosslinking experiments, and they have mapped the region required for dimerization. Overexpression of this protein led to a fused mitochondrial phenotype, yet they observed an increased recruitment of the fission GTPase Drp1. They can observe a complex containing overexpressed MIEF1 and Drp1, but an even better interaction between MIEF1 and hFis1. Silencing MIEF1 leads to a fragmented phenotype. The authors propose a role for MIEF1 as a suppressor of Drp1 activity, and potentially as an activator of mitochondrial tethering and/or fusion. Although they are clearly observing changes in mitochondrial morphology upon manipulation of MIEF1, this study does not provide a significant mechanistic advance into the understanding of mitochondrial fission or fusion. The data remains preliminary and require much more clarity to make this work of sufficient interest to the field.
1. The primary approach taken in this study is the overexpression of tagged forms of MIEF1, which, on it's own, is insufficient to conclude the biological activity of the endogenous protein. The overexpression of outer mitochondrial membrane proteins is particularly prone to artifactual clustering or clumping. This may be due to issues in protein turnover within the outer membrane, but make it essential that the authors examine the relationship between endogenous MIEF1 and Drp1, Fis1, Mff and Mfn2 (see below). The authors have an antibody that recognized endogenous MIEF1 (Figure 1 and 3A) which should be used for further biochemical experiments. 2. Most of the conclusions are drawn from indirect experiments and conjecture. The idea that MIEF1 is a suppressor of Drp1 is intriguing, however there is no idea how this is done. Does it affect the nucleotide dynamics within Drp1, its oligomerization, post-translational modifications, recycling rates on or off the membrane, etc.? The authors suggest that it may titrate Drp1 from hFis1, but this is never shown directly. The relationship with Mff is not tested at all, nor is any relationship with Mfn2 tested, although the discussion is full of speculation about a role for MIEF1 in fusion. 3. The authors use EM images to conclude that outer membranes have fused (Figure 2 ), which cannot be stated without additional evidence. To this reviewer, there is electron density between two adjacent mitochondria, where the outer membranes become obscured. These cells are also highly overexpressing, which will lead to artifacts so should be considered very carefully. 4. MIEF1 oligomerization: The authors use crosslinking to observe higher molecular weight products. The samples should be resolved using gel filtration to determine whether there is a stable higher order complex, or whether the crosslinkers are capturing a broad spectrum of intermediates. Drp1 and hFis (etc.) should also be probed on these gradients to determine whether there are distinct complexes or not. 5. Is hFis1 required for the interaction between MIEF1 and Drp1? Is Mff? Is Mfn2? These proteins should be silenced, then endogenous Drp1 IP'd with the commercial antibody, and the precipitate probed for endogenous MIEF1. Is Drp1 required for the interaction between MIEF1 and hFis (etc.)? 6. What is the functional impact of MIEF1-mediated regulation of Drp1 activity within the cell? Is there any change in its activity or levels during apoptosis? Does it bind to Bax, which has been implicated in mitochondrial fusion and fission by multiple groups in different systems? Does silencing MIEF1 render the cells hypersensitive to apoptosis? Does overexpression protect?
Minor points: 1. It is unclear why a "punctuate distribution of MIEF1" on mitochondria suggests it plays a role in longitudinal fusion? The authors are talking mostly about a role in fission and colocalization with Drp1? A punctate distribution could mean a lot of things. 2. The authors repeatedly conclude that a co-IP result means that two proteins "interact with each other" (example on p10). A co-IP shows that things reside in a precipitatable complex, but there may be many proteins in between. 3. The logic does not always flow well within the text. The authors make a strong case that MIEF1 is antagonistic to fission, yet the authors first consider that MIEF1 may be analagous to the Caf4/Mdv1/Fis1 adaptors. In the following paragraph they explain how it is unlikely. In this reviewers opinion, it is clear that MIEF1 is not analogous at all to the yeast system. On page 12 they say that hFis1 is the mitochondrial receptor for Drp1, yet in the discussion p16 the authors then cite the evidence that silencing hFis1 does not affect Drp1 recruitment. The authors should try to be more concise when presenting their arguments. 4. The methods section describes mitochondrial purification by kit, without any description of "reagent A, B or C". Then, on page 23 the composition of the mitochondrial buffer is not stated. 5. For consistency, the colors in panels 7D and E should be constant, with Drp1 in green and the mitotracker or MEIF1-V5 in red.
Generally we are left knowing very little about this system except that a protein with a transmembrane anchor does something to affect the distribution of Drp1. Therefore, this work remains at a preliminary stage. In particular, these very relevant points should be investigated in order to rely MIEF1 to the pathway of Drp1 recruitment and action on mitochondria.
Authors should explain better the approach used to identify MIEF1 in the public database. It appears that this database allows visual inspection of the overexpression of the tagged protein and hence authors used the images to address the effect of the overexpressed fusion protein on mitochondrial morphology. This must be explained.
We have added a more detailed description of the public intracellular protein localization database and our approach to select MIEF1 for detailed analysis. This is included in the first paragraph of the Results section.
Authors disregard the possibility that MIEF1 participates in mitochondrial fusion. This must be checked, by 1. measuring mitochondrial fusion rates; measuring the effect of its overexpression in cells deficient for fusion components.
This is a good point and we also appreciate the suggestion how to address this. We measured the effect of MIEF1 overexpression on mitochondrial fusion rate by a polyethylene glycol (PEG)-mediated in vivo cell fusion assay, and measured the extent of mitochondrial fusion by confocal microscopy. The cell fusion assay showed that overexpression of MIEF1 significantly increases mitochondrial fusion compared to empty vector control. This result has been included in new Figure  2L ,M. Furthermore, we examined the effect of MIEF1 overexpression in cells depleted of the fusion factor Mfn2 by RNAi. Depletion of Mfn2 leads to extensive mitochondrial fragmentation, and overexpression of MIEF1 in Mfn2-depleted cells induces extensive mitochondrial elongation, as shown in new Figure 3A ,B,C. Based on these new results, together with the original data presented in the manuscript (see Figures 1-3; Supplementary Figure S2 ), we conclude that MIEF1 plays a role in promoting mitochondrial fusion in addition to its role as an inhibitor of Drp1-mediated mitochondrial fission. The Results and Discussion sections are rewritten to reflect this fact (page 8, 9 and 18-19). We have re-arranged Figure 2 , including new EM data to more clearly present that MIEF1 promotes mitochondrial fusion.
3.
Levels of MIEF1 should be tested in different cell lines and tissues and related to the observed mitochondrial morphology.
In the original version of the manuscript, expression levels of MIEF1 in different cell lines were tested (see Figure 1B) , and this has now been complemented by analysis of MIEF1 mRNA expression levels in different human tissues (new Figure 1C) . We do not find a clear cut correlation between levels of MIEF1 and mitochondrial morphology in all cell lines. The lack of a direct correlation is likely the result of different levels of other interacting factors controlling the mitochondrial fission and fusion processes.
4.

Drp1 is known to migrate to mitochondria, oligomerize and promote fission. If MIEF1 is the key player in the pathway of Drp1 migration from the cytosol to mitochondria by playing together with hFis1, the analysis of expression levels of the endogenous versions of the three proteins during the process of MIEF1 mediated mitochondrial fusion is required.
We appreciate this comment. We have examined the expression levels of several key mitochondriashaping proteins including Drp1, hFis1, Mff and Mfn2 in cells overexpressing MIEF1 compared to control cells transfected with empty vector. MIEF1 overexpression did not affect the levels of these proteins in cells. The results are included in the new Figure 6C , and mentioned in the text (page 12).
5.
Overexpression This is an important point, and we thank the reviewer for drawing our attention to this. We accept the reviewer's comments that the dominant negative Drp1 K38A is due to its inability to hydrolyze GTP. However, the situation may be more complex, as a previous study showed that Drp1 K38A also affects distribution of endogenous Drp1 and reduces its mitochondrial localization (James et al, 2003) . In the revised version (page 11), we discuss this, hopefully in a balanced manner, and mention that the mitochondrial phenotypes induced by MIEF1 and Drp1
K38A are similar to a certain extent, but that it remains a possibility that the molecular mechanisms induced by MIEF1 and Drp1 K38A may be different.
We have used GTP-agarose pull-down assay and found that overexpression of MIEF1 partially reduces GTP binding of both endogenous Drp1 and exogenous HA-Drp1 (new Figure 7D ). This indicates that the GTPase activity of Drp1 may indeed be affected directly or indirectly by MIEF1.
The fact that both MIEF1 full-length and MIEF1 lacking the transmembrane region are equally efficient in promoting mitochondrial fusion is very confusing. Does this mean that MIEF1 overexpression equals Drp1 downregulation? Or do they belong to two different pathways? This must be addressed by checking the effect of Drp1 silencing on overexpression of the delta-TM MIEF1; and of overexpression of Drp1 constitutively located at the mitochondria (S637A) together with MIEF1.
We agree that these data are intriguing, but they are highly reproducible. It should however be noted that while both full-length MIEF1 and the mutant MIEF1 ∆1-48 lacking the transmembrane region were able to induce mitochondrial fusion, the phenotypes induced by wild-type MIEF1 and MIEF1 ∆1-48 are not completely identical, as summarized in Figure 4I . We apologize for not making this clear in the original version. Wild-type MIEF1 induces a compact cluster of mitochondria in more than 60% of 293T cells, but MIEF1 ∆1-48 , while triggering extensive mitochondrial elongation resulting in a tubular cluster of mitochondria, does not produce a compact cluster of mitochondria. Compared to wild-type MIEF1, in fact, the mitochondrial phenotype induced by MIEF1 ∆1-48 is more similar to that induced by Drp1 K38A , and also similar to that in 293T cells depleted of either endogenous Drp1 or Mff (see new data in Figure 4G and I). This is in keeping with the observation that both MIEF1 and MIEF1
∆1-48 can interact with Drp1 at the mitochondria or in the cytoplasm, respectively (see Figures 5 and 6 ). We believe that inhibition of Drp1 function via a MIEF1-Drp1 interaction is a crucial mechanism for the MIEF1-induced mitochondrial fusion phenotype, and consequently, MIEF1
∆160-169 lacking the ability to bind to Drp1 does not induce mitochondrial fusion ( Figure 6 A,B; Supplementary Figure S3 ). We however also believe that MIEF1 targeting to mitochondria is required for formation of a compact cluster of mitochondria, and the text has been modified to discuss all these data in a more balanced manner (page 12-13). In further support of this line of reasoning, we now also include new data, in response to the reviewer's request, on the effects of RNAi-mediated Drp1 silencing on mitochondrial morphology in cells expressing either wild-type MIEF1 or MIEF1 ∆1-48 . We find that depletion of Drp1 does not alter the mitochondrial phenotypes induced by either MIEF1 ∆1-48 or wild-type MIEF1 (new Figure 4H ), which we believe
To further address this issue, we also examined the effect of co-expressing MIEF1-V5 with either wild-type Myc-Drp1, the phosphorylation-deficient Figure S5 and the text (page 14).
Finally, Western blotting using a phosphorylation-specific Drp1 antibody, which specifically detects Drp1 phosphorylated at Ser637 (Cell Signaling), revealed that overexpression of MIEF1 does not affect the total level of Ser637 phosphorylated Drp1 ( Figure 7F ). Thus, MIEF1 exerted its function in the same way, irrespective of Drp1's phosphorylation status.
7.
The
role of Fis1 in mediating mitochondrial fission has been recently questioned. This must be discussed (see the recent work by Mihara and colleagues).
We thank the reviewer for pointing this out. This important work (Otera et al, 2010) , was published just after our manuscript was submitted, and we now discuss it in the revised version (page 19-20 This comment is well taken, and we agree that it is important to assess posttranslational modifications such as phosphorylation of Drp1 and how they may influence recruitment of Drp1 from the cytoplasm to mitochondria. Therefore, (and as discussed above, point 6) we first used a phospho-DRP1 (Ser637) antibody to test whether MIEF1 overexpression can affect the phosphorylation levels of Drp1 at the phosphorylation site Ser637. As shown in Figure 7F , we observed a low basal level of phosphorylated Drp1 in the cell, in keeping with several previous reports (Chang & Blackstone, 2007; Cribbs & Strack, 2007; Han et al, 2008) . MIEF1 overexpression does not alter the levels of Drp1 phosphorylated at Ser637 in the presence or absence of the protein kinase A (PKA) activator forskolin (new Figure 7F) . Second, and as mentioned above, MIEF1 can interact with wild-type Myc-Drp1, and its nonphosphorylatable and phosphomimetic mutants (S637A and S637D, respectively), and also recruit the mutated forms of Drp1 from the cytoplasm to mitochondria in similar manner (Supplementary Figure S5) .
Taken together, these data provide no indications that the MIEF1-mediated recruitment of Drp1 to mitochondria is linked to the phosphorylation status of Drp1 at Ser637 in cells, or conversely, that MIEF1-induced mitochondrial fusion should be accompanied by an altered phosphorylation level of Drp1.
Our data are consistent with the three previous studies mentioned by the reviewer that phosphorylation of Drp1 (such as the phosphomimetic Drp1 S637D mutation) inhibits mitochondrial fission, resulting in mitochondrial elongation (Supplementary Figure S5) , but it remained from the previous studies to be elucidated how non-phosphorylated Drp1 (which should represent a major fraction of endogenous Drp1 in cells), as well as the Drp1 S637A mutation (which cannot be phosphorylated) is recruited from the cytoplasm to mitochondria, resulting in mitochondrial fission (Cereghetti et al, 2008; Chang & Blackstone, 2007; Cribbs & Strack, 2007; Han et al, 2008) . In our hands, expression of Drp1 S637A alone did not produce an increase in mitochondrial fission (see Supplementary Figure S5A ). Moreover, a major proportion of Drp1 S637A was distributed in the cytoplasm (Supplementary Figure S5A) , a cellular distribution essentially similar to that observed for wild-type Myc-Drp1 and Drp1
S637D . This is consistent with one of previous studies (Chang & Blackstone, 2007) .
What is the role of MIEF1 during "physiological" fragmentation of mitochondria by Drp1? In other words, is it possible to inhibit translocation of Drp1 and hence fragmentation induced by Ca2+ overload by overexpressing MIEF1?
We appreciate this comment from the reviewer, and have made efforts to further address the role of MIEF1 in apoptosis and autophagy. The new data show that MIEF1 increases cleavage of the autophagy marker LC3B-I (to yield more LC3B-II), indicating that MIEF1 affects the activity of autophagy (new Figure 9C) , and whereas MIEF1 did not induce release of proapoptotic factors such as cytochrome c, Smac/Diablo and AIF (new Figure 9A) , a reduced increase in the level of cleaved PARP following staurosporine treatment was observed (new Figure 9D) , and conversely, RNAimediated knockdown of MIEF1 led to enhanced levels of cleaved PARP (new Figure 9E) . We also assessed whether MIEF1 had an impact on the cytoplasmic Ca 2+ concentration, but we did not, according to preliminary data, observe a difference in cytoplasmic Ca 2+ levels in response to staurosporine by MIEF1 overexpression as compared to empty vector control (shown to reviewers only Figure Finally, we observed a potential interaction between MIEF1 and Bax by co-IP, implying that MIEF1 may affect apoptosis via interaction with Bax. These data are currently shown to reviewers only (reviewers only Figure B . Figure not included in this Peer Review Process file). We would prefer, for space reasons, not to include the data in the revised version, but if deemed necessary by the reviewer and editor, we would be happy to do so. We realize that the role of MIEF1 in regulating "physiological" fragmentation of mitochondria may be complex and for a complete understanding these issues need to be addressed in the form of a new project.
Referee #2 (Remarks to the Author):
The authors report on a novel mitochondrial outer membrane protein, MIEF1, which plays a role in regulating mitochondrial fusion and fission processes. A mechanism explaining the recruitment of the mitochondrial fission factor Drp1 to the outer membrane is presented. In the proposed model DRP1 binds to MIEF1 which instead of promoting mitochondrial fission rather sequesters DRP1 in an inactive state. The mitochondria thus do not undergo any fission events whereas fusion was suggested to persist. On the contrary, hFis1 expression reverses this effect of MIEF1 indicating that the interplay between MIEF1 and hFis1 plays a crucial role in regulating the fission machinery.
The study is of major general interest and the experimental data are of high technical quality which largely support the conclusions of the authors. Only one major point and some minor points need to be addressed in my opinion.
Major point:
The authors claim that MIEF1 promotes mitochondrial elongation via ongoing fusion and inhibiting DRP1 function. Alternatively, MIEF1 e.g. via its homotypic interactions could promote mitochondrial clustering while at the same time mitochondrial fusion and fission is inhibited. The authors fail to address directly whether fusion is affected by MIEFThis needs to be done e.g. by a PA-GFP based assay or by an in vivo fusion assay.
This is a very good suggestion. We therefore performed an in vivo cell fusion assay and found that overexpression of MIEF1 significantly increases mitochondrial fusion (new Figure 2L and M) . In addition, we also studied the effect of MIEF1 overexpression on Drp1 mitochondrial localization and mitochondrial fusion in cells depleted of the fusion factor Mfn2. Consistent with a number of previous reports, depletion of endogenous Mfn2 results in extensive mitochondrial fragmentation. Overexpression of MIEF1 reverses the Mfn2 RNAi-mediated mitochondrial fragmentation phenotype, resulting in mitochondrial elongation in cells depleted of Mfn2 (new Figure 3A -C, page 9).
In the same direction, it rather looks that MIEF1 primarily promotes clustering of tubular mitochondria and that outer membrane, inner membrane fusion and fission is blocked. This is supported by their own EM data which show a major amount of docked outer membranes. On page 8, top paragraph the authors propose partial fusion of outer membranes (referring to figure 2K2 and 2K3). This is not convincingly shown as it rather appears that the OM is docked over the entire length of the membrane surface. The authors should thus investigate specifically also whether outer membrane fusion is inhibited or not. For this an in vivo fusion assay in combination with an outer membrane localized GFP is suggested.
The reviewer raises an important point. We have approached this issue by an in vivo cell fusion assay (see point 1, and also the response to reviewer 1).
We apologize that the EM data in the original version did not clearly convey the message. We have now rearranged the data and added new images to better portray the different steps in the process. In particular, in the new Figure 2H and I, J, K, we show a series of images reflecting the different steps in MIEF1-mediated fusion. We would also argue that the EM data re-constructed from serial ultrathin sections support the notion that there is a giant extended mitochondrion ( Figure 2E ), which was never observed in the control cells.
We have however not been able to get an in vivo assay with GFP-labelled outer membranes to work reproducibly, but we hope that the additional data from the EM, light microscopy, and in vivo cell fusion assay convincingly demonstrate that fusion takes place. We agree that the outer membranes to a large part are docked and sandwiched by electron dense material. This is a feature of the compact mitochondrial clusters, but there are also points of membrane fusion (Figure 2 , arrows).
Minor points:
To further corroborate the interaction between MIEF1 and Drp1 and the role of MIEF1 in recruiting DRP1 it would be good to target MIEF1 to other cellular membranes (e.g. cell membrane, Golgi etc.). Is DRP1 partly recruited to this artificial membrane localization as well?
This is a good suggestion, we have used a plasma membrane targeted CAAX motif to replace the TMD of MIEF1 and target MIEF1 to the plasma membrane. When expressed in 293T cells, MIEF1
Δ1-48 -CAAX became partially localized to the plasma membrane, where it is colocalized with endogenous Drp1, which appears as punctate structures on the plasma membrane, indicating that also when targeted to the plasma membrane, MIEF1 can capture Drp1 to this location. This result is currently shown only in the response to reviewer (reviewers only Figure C . Figure not included in this Peer Review Process file). We would prefer, for space reasons, not to include the data in the revised version, but if deemed necessary by the reviewer and editor, we would be happy to do so. figure 8D ) a colocalization analysis of the MIEF1 variants with labeled mitochondria (Mitotracker), and DRP1 should be shown -possibly as a supplemental material.
Do the different MIEF1 variants alter DRP1 distribution? In addition to the wild type MIEF1 (as shown in
We agree with the reviewer's comments. The Drp1 distribution in cells expressing different MIEF1 variants has been examined by confocal microscopy using triple-staining with MitoTracker followed by anti-Drp1 and anti-V5 tag antibodies. The results are shown as new Supplementary Figures 3 and  S4. 
3.
Fig. 2. The arrangement of EM micrographs is somehow confusing and one cannot get the information which image is the magnification of which one. Further there appears to be an error in the legend of figure 2 on page 32 stating that 2H and 2I are higher magnifications of 2G and 2H. It should say "(F and G, respectively)".
We are grateful to the reviewer for pointing this out. As discussed also with reviewer 1, we apologize that the EM data in the original version did not clearly convey the message, and were organized in a confusing order. We have now rearranged the data and added new images to better portray the different steps in the fusion process. In particular, in the new Figure 2I , J, K, we show a series of images reflecting the different steps in MIEF1-mediated fusion. We have also corrected all labeling mistakes in the revised version. Two areas in the new Figure 2H are magnified in 2I and 2K respectively as indicated.
4.
Fig. 9C. The Interaction of DRP1 to Fis1 is not convincingly shown. A stronger exposure needs to be shown.
We agree, and an image with a stronger exposure is now shown (new Figure 8C) .
5.
A
recent paper postulated Mff as a regulator of DRP1/hFis1-dependent fission (Otera et al, 2010). It would be nice but not essential to check whether MIEF1 and Mff are functionally linked or not.
This is a very good point, and as discussed with reviewer 1, the Otera et al., paper appeared in the literature after our manuscript was submitted. We show by RNAi experiments that depletion of Mff clearly decreases the level of Drp1 in mitochondria, consistent with the recent study (Otera et al, 2010) . Ectopic expression of MIEF1 can however, in a Mff-depleted setting, still re-recruit the cytoplasmic Drp1 to mitochondria, suggesting that MIEF1-mediated recruitment of Drp1 to mitochondria is not dependent on Mff (new Figure 7A-C) . Based on these new data, we suggest that MIEF1 plays a key role in inhibiting Drp1-induced mitochondrial fission, while Mff plays a key role in promoting Drp1-induced mitochondrial fission. Although both Mff and MIEF1 can recruit Drp1 to mitochondria, they are likely to have opposite effects on mitochondrial fission: positively and negatively regulating Drp1-mediated mitochondrial fission, respectively. A brief discussion on this is included in the revised version (page 20). Drp1, Fis1, Mff and Mfn2 (see below) . The authors have an antibody that recognized endogenous MIEF1 (Figure 1 and 3A) which should be used for further biochemical experiments.
Referee #3 (Remarks to the Author):
This manuscript presents a new factor in the regulation of mitochondrial morphology, MIEF1. Identified through a GFP-mapping project by
The primary approach taken in this study is the overexpression of tagged forms of MIEF1, which, on it's own, is insufficient to conclude the biological activity of the endogenous protein. The overexpression of outer mitochondrial membrane proteins is particularly prone to artifactual clustering or clumping. This may be due to issues in protein turnover within the outer membrane, but make it essential that the authors examine the relationship between endogenous MIEF1 and
We have explored the roles of endogenous Drp1, Fis1, Mff and Mfn2 (see point 2, below). We have also tried our outmost to get the antibody we have, and which indeed recognizes MIEF1, to work for co-immunoprecipitation experiments, but due to the low basal level of endogenous MIEF1 in the cell lines analyzed, we have been successful in obtaining consistent results only for some, but unfortunately not for all, combinations of interacting partners. We can however show that coimmunoprecipitation assay with an anti-MIEF1 rabbit antibody demonstrates an interaction between endogenous MIEF1 and Drp1, and that hFis1 was undetectable in this immunoprecipitated complex. Based on these data, we therefore speculate that MIEF1 may preferentially bind to Drp1 when the proteins are expressed at low levels in the cell. These data are currently shown as reviewers only Figure D . (Figure not included in this Peer Review Process file.) We would prefer, for space reasons, not to include the data in the revised version, but if deemed necessary by the reviewer and editor, we would be happy to do so.
To further address the potential interaction, we examined the subcellular localization of endogenous MIEF1 and Drp1 by confocal microscopy in HeLa cells, in which the level of endogenous MIEF1 is relatively high (Figure 1B ), and we demonstrate a partial co-localization on mitochondria for MIEF1 and Drp1 (new Figure 4C ).
2.
Most of the conclusions are drawn from indirect experiments and conjecture. The idea that MIEF1 is a suppressor of Drp1 is intriguing, however there is no idea how this is done. Does it affect the nucleotide dynamics within Drp1, its oligomerization, post-translational modifications, recycling rates on or off the membrane, etc.? The authors suggest that it may titrate Drp1 from hFis1, but this is never shown directly. The relationship with Mff is not tested at all, nor is any relationship with Mfn2 tested, although the discussion is full of speculation about a role for MIEF1 in fusion.
These are good comments, and we have extended the characterization of the role of MIEF1 in several ways. We have addressed whether MIEF1 overexpression can affect levels of GTP-binding to Drp1, its oligomerization, and post-translational modification. We have also addressed its relationship with Mff, as detailed below: 1). We have used a GTP-agarose pull-down assay and demonstrate that overexpression of MIEF1 partially reduces GTP-binding of both endogenous Drp1 and exogenous HA-Drp1 (new Figure 7D) .
2). By using in vivo chemical cross-linking (a similar approach as described by Blackstone and colleagues Zhu et al, 2004 )), we found no significant difference in the oligomerization levels of endogenous Drp1 in cells expressing MIEF1-V5 as compared to control cells transfected with empty vector (new Figure 7E ).
3). Using a phosphorylation-specific Drp1 polyclonal antibody recognizing phosphorylated Drp1 (Ser637), we show that MIEF1 overexpression does not alter the phosphorylation level of Drp1 at Ser637 in the presence or in the absence of the protein kinase A (PKA) activator forskolin, as described (Chang & Blackstone, 2007) (new Figure 7F ). 4). We examined the Drp1 distribution in cells depleted of Mff, Mfn2 and hFis1, respectively, and found that depletion of Mff by RNAi dramatically decreases mitochondrial localization of Drp1, in agreement with a recent study (Otera et al, 2010) . However, overexpression of MIEF1 in cells depleted of endogenous Mff re-recruits cytoplasmic Drp1 to mitochondria. Likewise, overexpressed MIEF1 could still recruit Drp1 to mitochondria in cells depleted of either endogenous Mfn2 or hFis1. Together, these data indicate that MIEF1-mediated recruitment of Drp1 to mitochondria is independent on Mff, Mfn2 and hFis1 (new Figure 7A-C) .
3.
The authors use EM images to conclude that outer membranes have fused (Figure 2 ), which cannot be stated without additional evidence. To this reviewer, there is electron density between two adjacent mitochondria, where the outer membranes become obscured. These cells are also highly overexpressing, which will lead to artifacts so should be considered very carefully.
As discussed also with reviewer 1 and 2, we apologize that the EM data in the original version did not clearly convey the message. We have now rearranged the data and added new images to better portray the different steps in the process. In particular, in the new Figure 2I ,J,K, we show a series of images reflecting MIEF1-mediated fusion. Please see also response to reviewer 2, point 2 and minor point 3.
4.
MIEF1 oligomerization: The authors use crosslinking to observe higher molecular weight products. The samples should be resolved using gel filtration to determine whether there is a stable higher order complex, or whether the crosslinkers are capturing a broad spectrum of intermediates. Drp1 and hFis1 (etc.) should also be probed on these gradients to determine whether there are distinct complexes or not. This is a valid point and we are grateful to the reviewer for this comment. We have tried to better resolve the issue of complex formation. We tested gel filtration, but ran into technical problems, and we therefore resorted to using native gel electrophoresis as an alternative approach. The new data show that MIEF1-V5 and Drp1 overlapped in complexes with sizes ~220 kDa and ~480-720 kDa, and MIEF1-V5 and hFis1 overlapped in a ~200 kDa complex, whereas there was almost no overlap between Drp1 and hFis1. These data have been included in the new Figure 8D and in the text (page 15).
5.
Is hFis1 Figure 7C ). In addition, these experiments demonstrate that knockdown of either Mff, Mfn2 or hFis1 by RNAi, does not affect the MIEF1-mediated recruitment of Drp1 to mitochondria (new Figure 7A and B) . Moreover, although depletion of Mff results in a decrease of Drp1 on mitochondria (in keeping with the recent report (Otera et al, 2010 )), we found that overexpression of MIEF1 re-recruits cytoplasmic Drp1 to mitochondria in Mff RNAi-treated cells (new Figure 7A and B, page 13).
Likewise, we demonstrate that RNAi-mediated depletion of Drp1 does not alter the interaction between MIEF1 and hFis1, suggesting that MIEF1 interacts separately with Drp1 and hFis1. These results have been included in the new Figure 8E and in the text (page 15). In summary, these new data show that neither Mff, nor hFis1, nor Mfn2 are essential for the MIEF1-Drp1 interaction and the MIEF1-mediated recruitment of Drp1 to mitochondria.
6.
What is the functional impact of MIEF1-mediated regulation of Drp1 activity within the cell? Is there any change in its activity or levels during apoptosis? Does it bind to Bax, which has been implicated in mitochondrial fusion and fission by multiple groups in different systems? Does silencing MIEF1 render the cells hypersensitive to apoptosis? Does overexpression protect?
We appreciate this comment, and acknowledge that the original version of the manuscript fell a bit short on the significance of MIEF1 in the cell death process (see also discussion with reviewer 1). We have therefore examined the effect of MIEF1 on apoptosis in several ways. We also identify a role for MIEF1-mediated mitochondrial fusion in cell autophagy. Ectopic expression of MIEF1 induces cell autophagy as indicated by an increase in cleaved LC3B (LC3B-II) in cells expressing MIEF1 (new Figure 9D) . Furthermore, whereas MIEF1 did not induce release of proapoptotic factors such as cytochrome c, Smac/Diablo and AIF (new Figure 9A) , a reduced increase in the level of cleaved PARP following staurosporine treatment was observed (new Figure 9B) , and conversely, RNAi-mediated knockdown of MIEF1 led to enhanced levels of cleaved PARP (new Figure 9C) . Minor points:
1.
It is unclear why a "punctuate distribution of MIEF1" on mitochondria suggests it plays a role in longitudinal fusion? The authors are talking mostly about a role in fission and colocalization with Drp1? A punctate distribution could mean a lot of things.
We agree to this, and we have therefore modified the description of MIEF1 distribution on mitochondria and removed the last sentence in this paragraph (page 8).
The authors repeatedly conclude that a co-IP result means that two proteins "interact with each other" (example on p10). A co-IP shows that things reside in a precipitatable complex, but there may be many proteins in between.
We apologize for the sloppy habit of equating co-IP with direct interactions; we know better and agree that co-IP data could reflect higher order complexes. The text has been modified accordingly.
3.
The This is a valid point. We have gone through the manuscript to clear it from internal contradictions. As a result of this, the Discussion has been thoroughly restructured, and shortened, which hopefully brings the interpretation of data across more clearly.
4.
The methods section describes mitochondrial purification by kit, without any description of "reagent A, B or C". Then, on page 23 the composition of the mitochondrial buffer is not stated.
We apologize for these omissions, and have modified the Materials & Methods to more clearly describe the experimental procedures. The composition of the mitochondrial buffer has been included in the method section describing proteinase K digestion experiments in Supplementary data. Additionally, we also used a mitochondria isolation kit (Pierce) according to the manufacturer's instructions, in which there was no description of "reagent A, B or C" available.
5.
For consistency, the colors in panels 7D and E should be constant, with Drp1 in green and the mitotracker or MIEF1-V5 in red. This is a valid point. We have made new experiments and modified the images to be consistent between Figure 7D and E (shown as Figure 5D and E in the revised version). We now include confocal images with triple-staining using MitoTracker followed by immunostaining with anti-HA (green) and V5 (blue) antibodies (new Figure 5E ).
Generally we are left knowing very little about this system except that a protein with a transmembrane anchor does something to affect the distribution of Drp1. Therefore, this work remains at a preliminary stage.
Obviously, we disagree with this comment, and are pleased to see that reviewers 1 and 2 find the data to be of interest for our understanding of mitochondrial dynamics. We believe that the characterization of a novel protein in this process and working out its relationship with previously known players in the process represents a significant advance in the field. Thank you for sending us your revised manuscript. Our original referees 2 and 3 have now seen it again, and you will be pleased to learn that in their view you have addressed their criticisms in a satisfactory manner, and that the paper will therefore be publishable in The EMBO Journal.
Still, I was wondering whether you would like to consider addressing the minor issues suggested by the referees (see below). In particular, please cite and discuss the recent EMBO reports article (Palmer et al. 2011 ; PMID: 21508961) mentioned by referee 3 in the discussion section of your manuscript.
In addition, there are two editorial issues that need further attention. According to our new policies, I need to ask you to include an author contribution section into the manuscript text. Furthermore, please include the number of independent repeats into the legend of figure 1C .
Please let us have a suitably amended manuscript as soon as possible. I will then formally accept the manuscript.
Yours sincerely,
Editor
The EMBO Journal REFEREE REPORTS Referee #2 (Remarks to the Author):
In this study the role of the novel mitochondrial outer membrane protein, MIEF1, in regulating mitochondrial dynamics was extensively studied. The revised version of the manuscript has improved a lot providing much more mechanistic insights compared to the initial version. The abundance of data is impressive and the study addresses well and logically the molecular function of MIEF1 and its domains. All our suggestions and questions have been sufficiently addressed.
There are only some minor remarks still to consider. In Fig. 5F they should include a negative control (without MIEF1) as done in the experiment shown in Fig. 4D . Fig. S3 and S4 should be combined -the data are partly redundant.
Taken together, the study is of major general interest, all major conclusions are well supported, and it was technically very well done.
Referee #3 (Remarks to the Author):
This manuscript has been vastly improved and the authors have carefully addressed all of my points. By exploring the relationship between MIEF1 and a number of factors relevant to mitochondrial morphology, it is now possible to place MIEF1 as a very novel factor that regulates the process of fission and fusion in a rather exclusive manner (it both blocks fission and activates fusion). The authors have presented the reviewers with evidence of some co-IP with endogenous MIEF1 and Drp1 (hFis1 is not present). This IP is not very robust, however I appreciate the idea that the activation state of MIEF1 in cells may be low in steady state, so this interaction will likely be explored further under varying physiological conditions. Therefore I thank the authors for their consideration of my recommendations and believe that this manuscript will offer new insights to the community.
Finally, in the last few days a manuscript has appeared in EMBO Reports characterizing the same cDNA (EMBO Rep. 2011 Apr 21), so I would suggest the authors include a note in proof, or at least within the keywords so the field realizes that two labs have both confirmed a role for MIEF1 in mitochondrial dynamics.
2nd Revision -authors' response 18 May 2011
Response to the reviewers
We appreciate very much the positive comments on our revised manuscript. We would like to take this opportunity to thank the reviewers again for their insightful and constructive comments and suggestions that led to significant improvements of the manuscript. Responses to specific comments raised by the reviewers are included below.
In There are only some minor remarks still to consider. In Fig. 5F they should include a negative control (without MIEF1) as done in the experiment shown in Fig. 4D . Fig. S3 and S4 should be combined -the data are partly redundant.
We have added a negative control in Figure 5F . Figures S3 and S4 have been combined as a new Figure S3 that is included in the Supplementary information. We agree that exploring the interaction of endogenous MIEF1 with endogenous Drp1 and hFis1 is of interest in order to further understand the potential physiological role of MIEF1 in regulating mitochondrial dynamics. We will therefore pay attention to this issue in the future. Thank you for sensing us your re-revised manuscript. I have now had a chance to look at the changes you made, and I realised that there is one issue that still needs further attention. As mentioned in my previous letter, a similar paper has been published in EMBO reports during the revision period. A "Note added in proof" will therefore not be sufficient. Rather, as specified earlier, I need to ask you to discuss this paper (Palmer et al. 2011) in the discussion section of your manuscript and to cite it in the reference list. Please send us a suitably amended manuscript text file via e-mail. We will upload it to the system for you.
Finally
Thank you very much for your cooperation.
Editor
The EMBO Journal
